Complications related to therapeutic anticoagulation in total hip arthroplasty.

Autor: McDougall CJ; The Prince Charles Hospital Orthopaedic, Research and Audit Unit, The Prince Charles Hospital, Brisbane, Queensland, Australia., Gray HS, Simpson PM, Whitehouse SL, Crawford RW, Donnelly WJ
Jazyk: angličtina
Zdroj: The Journal of arthroplasty [J Arthroplasty] 2013 Jan; Vol. 28 (1), pp. 187-92.
DOI: 10.1016/j.arth.2012.06.001
Abstrakt: Bleeding-related wound complications cause significant morbidity in lower limb arthroplasty surgery. Patients who require therapeutic anticoagulation in the perioperative period are potentially at higher risk for these complications. This is a retrospective case-control study reviewing all primary total hip arthroplasties performed in a single center during a 5-year period and comparing outcomes of the patients on warfarin with a double-matched control group of patients not on warfarin. The warfarin group had a significantly higher risk of deep joint infection (9% vs 2.2%), hematoma/wound ooze (28% vs 4%), and superficial infection (13.5% vs 2.2%). Managing patients undergoing total hip arthroplasty with therapeutic anticoagulation is a balance between the risk of thromboembolic disease and bleeding-related complications. Improved understanding of this risk will better allow patients to make an informed decision regarding their elective arthroplasty surgery.
(Copyright © 2013 Elsevier Inc. All rights reserved.)
Databáze: MEDLINE
Externí odkaz: